T1	Participants 121 161	patients with superficial bladder tumors
T2	Participants 363 394	prospective, single institution
T3	Participants 568 632	301 patients underwent transurethral resection of bladder tumors
T4	Participants 1025 1087	191 patients with superficial bladder carcinoma were available
